Prior to the rule’s release, ASA had asked CMS to consider anesthesiology and adopt a broader definition of anesthesiologists to be excluded from the requirements.
CMS explained its reasoning by stating that anesthesiologists do not interact with patients in a manner conducive to collecting information for meaningful use. They also listed anesthesiology with radiology and pathology as lacking face-to-face patient interaction and needing to follow up frequently with patients.
The exemption is subject to annual renewal, and ASA will continue to work with CMS to come up with a more permanent fix as it begins to address Stage 3.
More Articles on Anesthesia:
AcelRx Begins Final Testing Phase for Patient-Controlled Analgesia System
Dr. Timothy Starck Elected Vice President of Illinois Society of Anesthesiologists
Academic Anesthesia Departments Report Insufficient Support
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
